A 16-Year-Old Female Runner with Prolonged QT Interval

  • Sandeep Basavarajaiah
  • Sanjay SharmaEmail author


A 16-year-old female long-distance runner underwent a cardiovascular evaluation as a part of pre-participation screening programme. She trained approximately 18 h per week and was competing at national level. She was asymptomatic and had no significant past medical history. She denied any regular use of medications or drugs. There was no family history of syncope, premature cardiovascular disease, epilepsy or sudden cardiac death in close relatives.


Sudden Cardiac Death Significant Past Medical History Premature Cardiovascular Disease Congenital LQTS Asymptomatic Athlete 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Schwartz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J 1975, 89:378–390PubMedCrossRefGoogle Scholar
  2. 2.
    Moss AJ. Prolonged QT syndromes. JAMA 1986, 256:2985–2987PubMedCrossRefGoogle Scholar
  3. 3.
    Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000, 102:1178PubMedGoogle Scholar
  4. 4.
    Schwartz PJ. The long QT syndrome. Curr Probl Cardiol 1997, 22:297PubMedCrossRefGoogle Scholar
  5. 5.
    Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103:89PubMedGoogle Scholar
  6. 6.
    Quaglini S, Rognoni C, Spazzolini C, Priori SG, Mannarino S, Schwartz PJ. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J 2006, 27:1824PubMedCrossRefGoogle Scholar
  7. 7.
    Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992, 327:846PubMedCrossRefGoogle Scholar
  8. 8.
    Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005, 294:2975PubMedCrossRefGoogle Scholar
  9. 9.
    Basavarajaiah S, Shah A, Sharma S. Sudden cardiac death in young athletes. Heart 2007, 93(3):287–289PubMedCrossRefGoogle Scholar
  10. 10.
    Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998, 338:1709PubMedCrossRefGoogle Scholar
  11. 11.
    Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003, 289:2120PubMedCrossRefGoogle Scholar
  12. 12.
    Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Eng J Med 1998, 339(6):364–369CrossRefGoogle Scholar
  13. 13.
    Basavarajaiah S, Wilson M, Whyte G, Shah A, Behr E, Sharma S. Prevalence and significance of an isolated long QT interval in elite athletes. Eur Heart J 2007, 28:2944–2949Google Scholar
  14. 14.
    Moss A. Measurement of the QT interval and the risk associated with QTc prolongation: a review. Am J Cardiol 1993, 72:23BPubMedCrossRefGoogle Scholar
  15. 15.
    Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. Risk stratification in the long-QT syndrome. N Engl J Med 2003, 348(19):1866–1874PubMedCrossRefGoogle Scholar
  16. 16.
    Maron BJ, Isner JM, McKenna WJ. Twenty-sixth Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol 1994, 24(4):880–885PubMedCrossRefGoogle Scholar
  17. 17.
    Pelliccia A, Corrado D, Bjornstad HH, Panhuyzen-Goedkoop N, Urhausen A, Carre F, Anastasakis A, Vanhees L, Arbustini E, Priori S. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006, 13(6):876–885PubMedCrossRefGoogle Scholar
  18. 18.
    Groh WJ, Silka MJ, Oliver RP, et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996, 78:703PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2009

Authors and Affiliations

  1. 1.Department of CardiologyKing’s College HospitalLondonUK
  2. 2.Department of CardiologyEssex Cardiothoracic CentreEngland

Personalised recommendations